| Date23.11.2017 |
TitleThird Global Iron Deficiency Day to Raise Awareness of the Symptoms of Iron Deficiency |
Download
Third Global Iron Deficiency Day to Raise Awareness of the Symptoms of Iron Deficiency
|
| Date27.09.2017 |
TitleVifor Pharma Expands Exclusive License Agreement for The Commercialisation of Mircera® in the US |
Download
Vifor Pharma Expands Exclusive License Agreement for The Commercialisation of Mircera® in the US
|
| Date08.08.2017 |
TitleVifor Pharma Reports Strong H1 2017 Results and Raises Guidance |
Download
Vifor Pharma Reports Strong H1 2017 Results and Raises Guidance
|
| Date21.07.2017 |
TitleEuropean Commission Approves Marketing Authorisation for Veltassa® |
Download
European Commission Approves Marketing Authorisation for Veltassa®
|
| Date18.07.2017 |
TitleNew Expert Review in the American Journal of Hematology Seeks to Change the Way We Test, Treat and Talk About Iron Deficiency in Chronic Inflammatory Conditions |
Download
New Expert Review in the American Journal of Hematology Seeks to Change the Way We Test, Treat and Talk About Iron Deficiency in Chronic Inflammatory Conditions
|
| Date12.07.2017 |
TitleVifor Pharma Announces Three Outcomes Trials in Heart Failure and Iron Deficiency |
Download
Vifor Pharma Announces Three Outcomes Trials in Heart Failure and Iron Deficiency
|
| Date09.06.2017 |
TitleKissei to Market Avacopan in Japan for Vifor Fresenius Medical Care Renal Pharma |
Download
Kissei to Market Avacopan in Japan for Vifor Fresenius Medical Care Renal Pharma
|
| Date19.05.2017 |
TitleChmp Recommends Veltassa® for the Treatment of Hyperkalaemia in the EU |
Download
Chmp Recommends Veltassa® for the Treatment of Hyperkalaemia in the EU
|
| Date16.05.2017 |
TitleVifor Pharma and Akebia Announce Exclusive License Agreement to Provide Vadadustat to Fresenius Medical Care in the U.S. Upon FDA Approval |
Download
Vifor Pharma and Akebia Announce Exclusive License Agreement to Provide Vadadustat to Fresenius Medical Care in the U.S. Upon FDA Approval
|
| Date11.05.2017 |
Title89th Annual General Meeting of Galenica Ltd. |
Download
89th Annual General Meeting of Galenica Ltd.
|
| Date12.04.2017 |
TitleGalenica Santé IPO – Full exercise of over-allotment option |
Download
Galenica Santé IPO – Full exercise of over-allotment option
|
| Date07.04.2017 |
TitleSuccessful Galenica Santé IPO, Galenica Group becomes Vifor Pharma Group |
Download
Successful Galenica Santé IPO, Galenica Group becomes Vifor Pharma Group
|
| Date03.04.2017 |
TitleIPO Galenica Santé: Galenica announces narrowed price range and upsizing of the IPO |
Download
IPO Galenica Santé: Galenica announces narrowed price range and upsizing of the IPO
|
| Date24.03.2017 |
TitleGalenica launches IPO of Galenica Santé and sets price range |
Download
Galenica launches IPO of Galenica Santé and sets price range
|
| Date24.03.2017 |
TitleAdvance information IPO of Galenica Santé |
Download
Advance information IPO of Galenica Santé
|
| Date21.03.2017 |
TitleCOMCO ruling against HCI Solutions Ltd. |
Download
COMCO ruling against HCI Solutions Ltd.
|
| Date14.03.2017 |
TitleGalenica announces plans for IPO of Galenica Santé on SIX Swiss Exchange |
Download
Galenica announces plans for IPO of Galenica Santé on SIX Swiss Exchange
|
| Date14.03.2017 |
TitleBoard of Directors launches “Milestone 2020” strategy plan: Galenica Group to become Vifor Pharma Group and float Galenica Santé on the stock exchange |
Download
Board of Directors launches “Milestone 2020” strategy plan: Galenica Group to become Vifor Pharma Group and float Galenica Santé on the stock exchange
|
| Date14.03.2017 |
TitleResults of the Galenica Group 2016 |
Download
Results of the Galenica Group 2016
|
| Date22.02.2017 |
TitleGalenica Santé adds Merfen® and Vita-Merfen® to its OTC product portfolio |
Download
Galenica Santé adds Merfen® and Vita-Merfen® to its OTC product portfolio
|
| Date20.02.2017 |
TitleVifor Pharma Continues Commitment to Raise Awareness of Iron Deficiency |
Download
Vifor Pharma Continues Commitment to Raise Awareness of Iron Deficiency
|
| Date14.02.2017 |
TitleVifor Pharma and ChemoCentryx Announce Expansion of Avacopan Agreement for Rare Renal Diseases |
Download
Vifor Pharma and ChemoCentryx Announce Expansion of Avacopan Agreement for Rare Renal Diseases
|
| Date19.01.2017 |
TitlePlanned division of the Galenica Group |
Download
Planned division of the Galenica Group
|
| Date19.01.2017 |
Title2016 sales of the Galenica Group |
Download
2016 sales of the Galenica Group
|
| Date11.01.2017 |
TitleThe Galenica Group is taking over SD wholesaler Pharmapool |
Download
The Galenica Group is taking over SD wholesaler Pharmapool
|
| Date09.01.2017 |
TitleChange to the shareholder structure of the Galenica Group |
Download
Change to the shareholder structure of the Galenica Group
|